Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-08-12Clinical Trial Update: High-Dose Melphalan and a Second Stem Cell Transplant or Low-Dose Cyclophosphamide in Treating Patients With Relapsed Multiple Myeloma After Chemotherapy [Phase 3]
This Phase 3 clinical trial compares high-dose melphalan with a second stem cell transplant to low-dose cyclophosphamide for patients with r…
-
CLINICAL_TRIALS trial_result · 2013-08-12Clinical Trial Update: High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients With Newly Diagnosed Stage I, Stage II, or Stage III Multiple Myeloma [Phase 2]
This entry describes a Phase 2 clinical trial evaluating high-dose chemotherapy followed by stem cell transplantation in patients with newly…
-
CLINICAL_TRIALS trial_result · 2013-08-09Clinical Trial Update: A Study to Assess the Safety and Efficacy of MUC1 Peptide Vaccine and hGM-CSF in Patients With MUC1-positive Tumor Malignancies [Phase 1, Phase 2]
The completed Phase 1/2 trial evaluated the safety and preliminary efficacy of a MUC1 peptide vaccine in combination with hGM-CSF for patien…
-
CLINICAL_TRIALS trial_result · 2013-08-08Clinical Trial Update: Study of Mapatumumab in Combination With Bortezomib (Velcade) and Bortezomib Alone in Subjects With Relapsed or Refractory Multiple Myeloma [Phase 2]
A Phase 2 trial evaluated mapatumumab in combination with bortezomib versus bortezomib alone in relapsed or refractory multiple myeloma. The…
-
CLINICAL_TRIALS trial_result · 2013-08-02Clinical Trial Update: Dose Escalation Study of MLN0128 in Relapsed or Refractory Multiple Myeloma or Waldenstrom Macroglobulinemia [Phase 1]
A Phase 1 dose-escalation study of MLN0128 in relapsed or refractory multiple myeloma and Waldenström macroglobulinemia has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-08-02Clinical Trial Update: Pilot Study of Reduced-Intensity Umbilical Cord Blood Transplantation in Adult Patients Wtih Advanced Hematopoietic Malignancies
The trial evaluating reduced-intensity umbilical cord blood transplantation in adults with advanced hematopoietic malignancies has been term…
-
CLINICAL_TRIALS trial_result · 2013-08-02Clinical Trial Update: Music Therapy on Nausea and Pain for Autologous Stem Cell [NA]
A completed trial evaluating music therapy to reduce nausea and pain in patients undergoing autologous stem cell transplantation for multipl…
-
CLINICAL_TRIALS trial_result · 2013-07-31Clinical Trial Update: QUIREDEX: Revlimid (Lenalidomide) and Dexamethasone (ReDex) Treatment Versus Observation in Patients With Smoldering Multiple Myeloma With High Risk of Progression [Phase 3]
A Phase 3 study (QUIREDEX) evaluating lenalidomide plus dexamethasone versus observation in patients with smoldering multiple myeloma at hig…
-
CLINICAL_TRIALS trial_result · 2013-07-18Clinical Trial Update: Combination Chemotherapy in Treating Patients With Multiple Myeloma [Phase 2]
A Phase 2 trial of combination chemotherapy in patients with multiple myeloma and plasma cell neoplasm has completed.
-
CLINICAL_TRIALS trial_result · 2013-07-18Clinical Trial Update: Safety and Dose Determining Study of BT062 in Patients With Relapsed or Refractory Multiple Myeloma [Phase 1]
Phase 1 safety and dose-determining study of BT062 in relapsed or refractory multiple myeloma has been completed.
-
CLINICAL_TRIALS trial_result · 2013-07-18Clinical Trial Update: Rituximab in Treating Patients With Multiple Myeloma [Phase 2]
Phase 2 clinical trial evaluating rituximab for multiple myeloma and related plasma cell neoplasms has completed.
-
CLINICAL_TRIALS trial_result · 2013-07-17Clinical Trial Update: S0204 Thalidomide, Chemotherapy, and Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma [Phase 2]
This Phase 2 trial evaluated thalidomide in combination with chemotherapy and peripheral stem cell transplantation for multiple myeloma; the…
-
CLINICAL_TRIALS trial_result · 2013-07-17Clinical Trial Update: S0232 Dexamethasone With or Without Lenalidomide in Treating Patients With Previously Untreated Stage I, Stage II, or Stage III Multiple Myeloma [Phase 3]
Phase 3 trial S0232 assessed dexamethasone with or without lenalidomide in previously untreated Stage I–III multiple myeloma. The study resu…
-
CLINICAL_TRIALS trial_result · 2013-07-17Clinical Trial Update: Quality of Life of Non-transplant Candidate Multiple Myeloma Patients Treated With Early Bortezomib
This completed clinical trial assesses quality of life in non-transplant candidate multiple myeloma patients treated with early bortezomib.
-
CLINICAL_TRIALS trial_result · 2013-07-17Clinical Trial Update: Acupuncture for Chemotherapy-induced Peripheral Neuropathy [NA]
This entry describes an ongoing clinical trial evaluating acupuncture for chemotherapy-induced peripheral neuropathy in patients with lympho…
-
CLINICAL_TRIALS trial_result · 2013-07-16Clinical Trial Update: SNP-Based Prediction of Oral Mucositis Risk in Patients Receiving Hematopoietic Stem Cell Transplants (HSCT)
The completed trial conducted by Dana-Farber Cancer Institute evaluated SNP-based genetic markers for predicting oral mucositis risk in pati…
-
CLINICAL_TRIALS trial_result · 2013-07-11Clinical Trial Update: SU5416 in Treating Patients With Refractory or Relapsed Multiple Myeloma [Phase 2]
This is a Phase 2 clinical trial update on SU5416 for patients with refractory or relapsed multiple myeloma, with the study status noted as …
-
CLINICAL_TRIALS trial_result · 2013-07-11Clinical Trial Update: Infusion of Genetically Modified T Cell for Post Transplant Patients With Relapsed Disease [Phase 1]
Phase 1 clinical trial evaluating infusion of genetically modified T cells in post-transplant patients with relapsed disease has completed. …
-
CLINICAL_TRIALS trial_result · 2013-07-11Clinical Trial Update: Allogeneic Bone Marrow Transplantation From Unrelated Donors in Multiple Myeloma
Clinical trial evaluating allogeneic bone marrow transplantation from unrelated donors in patients with multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2013-07-10Clinical Trial Update: Isotretinoin Plus Dexamethasone in Treating Patients With Multiple Myeloma [Phase 2]
Phase 2 clinical trial of isotretinoin plus dexamethasone for multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2013-07-04Clinical Trial Update: A Study of JNS002 (Doxorubicin Hydrochloride Liposome Injection) in Relapsed or Refractory Multiple Myeloma [Phase 1]
This document summarizes a completed Phase 1 study of JNS002 (doxorubicin hydrochloride liposome injection) in relapsed or refractory multip…
-
CLINICAL_TRIALS trial_result · 2013-07-03Clinical Trial Update: Epoetin Alfa in Treating Anemia in Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma and Anemia Caused By Chemotherapy [Phase 3]
This Phase 3 trial evaluated epoetin alfa for treating anemia in patients with lymphoma, chronic lymphocytic leukemia, or multiple myeloma w…
-
CLINICAL_TRIALS trial_result · 2013-07-02Clinical Trial Update: A Phase 1 Dose Escalation Study of TAK-901 in Subjects With Advanced Hematologic Malignancies [Phase 1]
A Phase 1 dose-escalation study of TAK-901 in subjects with advanced hematologic malignancies; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2013-07-01Clinical Trial Update: Lenalidomide in Treating Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant [Phase 3]
Phase 3 clinical trial update evaluating lenalidomide in patients with multiple myeloma undergoing autologous stem cell transplantation; res…
-
CLINICAL_TRIALS trial_result · 2013-07-01Clinical Trial Update: Lenalidomide in Treating Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant [Phase 3]
Phase 3 clinical trial update evaluating lenalidomide in patients with multiple myeloma undergoing autologous stem cell transplant; status A…